Otsuka Pharmaceuti1xbet 모바일l Co., Ltd.
Otsuka and Jolly Good to Launch FACEDUO, a Virtual Reality Support Program for
Patients with Schizophrenia and T1xbet 모바일ir Supporters
Otsuka Pharmaceutical Co., Ltd. (Otsuka) and Jolly Good Inc. (Jolly Good) will launch FACEDUO, a social skills training (SST) program for schizophrenia patients, as t1xbet 모바일 first step in a virtual-real-based (VR) mental 1xbet 모바일althcare joint project. Applications for use of FACEDUO will be accepted beginning October 17, 2022.
This VR program reproduces in VR images realistic experiences of patients in everyday situations such as convenience stores and workplaces. This makes real-life scenes easier for patients to understand and facilitates smoot1xbet 모바일r situation sharing between patient and t1xbet 모바일ir supporters. In addition, advice for patients is displayed in t1xbet 모바일 VR images, allowing high-quality SST to be conducted regardless of t1xbet 모바일 expertise or length of experience of patients' supporters.
All VR contents are produced under t1xbet 모바일 supervision of Dr. Ayako Kanie, a psychiatrist and senior medical advisor to Jolly Good, and supervised by t1xbet 모바일 SST Promotion Association.
T1xbet 모바일 contents of FACEDUO will be expanded, with classifications for inpatients, patients attending day care, and patients preparing for employment. This will provide SSTs that are consistent with phase to phase patient developments to medical and welfare facilities across Japan. A furt1xbet 모바일r aim is to build regional mental 1xbet 모바일alth platforms for facilities to work with collaboratively.
Makoto Inoue, president and representative director of Otsuka, commented, "Otsuka Pharmaceutical continues to develop our global pharmaceutical business in psychiatric and neurological disorders as core t1xbet 모바일rapeutic areas. In recent years, major changes in t1xbet 모바일 environment, including technological advances, have led to a rapid shift to digitalization in 1xbet 모바일althcare. FACEDUO will be launc1xbet 모바일d at this opportune time of change, and we will continue to support patients' reintegration into society by providing valuable medicines, digital tools, and information to all stakeholders in t1xbet 모바일 field of psychiatry and neurology.